Physician profile
Robert Torrey
NPI 1528178803
$1,348.12
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $435 · 2021: $251 · 2022: $80.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $628.63 | 2019-2020 | |
| Pfizer INC. | $215.12 | 2019-2021 | |
| Astellas Pharma US INC | $194.45 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.04 | 2019-2022 | |
| Abbvie INC. | $69.12 | 2021 | |
| Myovant Sciences INC. | $55.89 | 2021-2022 | |
| Cook Medical LLC | $46.08 | 2021 | |
| Allergan, INC. | $24.66 | 2019 | |
| Janssen Biotech, INC. | $22.79 | 2021 | |
| Boston Scientific Corporation | $19.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Torrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.